Percutaneos Liver Biopsy in Pediatric Patient : Diagnostic Significance and Pattern of Liver Diseases

Launched by ASSIUT UNIVERSITY · Jan 9, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at a procedure called a percutaneous liver biopsy, which is a way to take a small sample of liver tissue to help doctors understand liver diseases in children. The main goal of the study is to find out what types of liver diseases can be diagnosed using this method in young patients. The trial will review liver biopsy reports from children under 18 years old who were suspected of having liver problems and were treated at Assiut University Children Hospital between January 2019 and December 2023.

To be part of this study, children must be under 18 years old and have had a liver biopsy during their hospital stay. Unfortunately, children over 18 or those suspected of having Wilson Disease will not be included because special tests needed to diagnose that condition are not available. While the study is not yet recruiting participants, it aims to provide valuable insights into liver diseases in children, which may help improve future diagnosis and treatment options.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All liver biopsy reports taken from infants and children with suspected liver disease aged less than 18 years between January 2019 and December 2023 who had been admitted in Pediatric Gastroenterology and Hepatology unit, Assiut University Children Hospital will be reviewed and included in the study.
• Exclusion Criteria:
• • Patients more than 18 years of age. Children with suspected Wilson Disease due to non-availability of the special stains used for histological diagnosis of the disease.